Lung Cancer News and Research

Latest Lung Cancer News and Research

Risk prediction model does not accurately identify lung cancer risks in diverse population

Lung cancer is the third most common cancer in the U.S. and the leading cause of cancer death, with about 80% of the total 154,000 deaths recorded each year caused by cigarette smoking. Black men are more likely to develop and die from lung cancer than persons of any other racial or ethnic group, pointing to severe racial disparities.

5 May 2021

PET imaging can enable accurate diagnosis of recurring brain metastases

For patients with brain metastases, amino acid positron emission tomography (PET) can provide valuable information about the effectiveness of state-of-the-art treatments.

5 May 2021

Study identifies novel combination therapy to help patients with advanced lung cancer

A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to immunotherapy in people diagnosed with advanced lung cancer.

5 May 2021

Study aims to refine delivery of tobacco treatment to people with HIV

Researchers at MUSC Hollings Cancer Center have received more than $2 million from the National Cancer Institute (NCI) to evaluate the impact of a proactive opt-out approach to smoking cessation on the health outcomes of people living with HIV.

30 Apr 2021

Controversial celebrities' illness may negatively affect people's health intentions

Not all public figures are equally beloved, and sometimes when more controversial celebrities get sick, it may negatively affect people's health intentions.

30 Apr 2021

Secondhand smoke exposure linked to higher risk of oral cancer

People who are exposed to secondhand smoke could have a 51% higher risk of developing oral cancer, suggests a review of existing research published online in the journal Tobacco Control.

27 Apr 2021

Researchers identify genetic abnormalities that drive invasiveness in head and neck cancer

A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.

26 Apr 2021

Study offers insight into how damage to airways of the lung develops into pre-cancer lesions

Lung carcinomas are the leading cause of cancer-related deaths in the United States and worldwide. Lung squamous cell carcinomas (non-small cell lung cancers that arise in the bronchi of the lungs and make up approximately 30 percent of all lung cancers) are poorly understood, particularly with respect to the cell type and signals that contribute to disease onset.

26 Apr 2021

Preoperative sarcopenia and exercise intolerance predict outcomes following lung cancer surgery

Lung cancer is a major global cause of mortality, reportedly accounting for 1.7 million deaths each year. The most common form of lung cancer is non-small-cell lung cancer (NSCLC), and early-stage NSCLCs can often be surgically resected.

26 Apr 2021

Contralateral esophagus sparing technique can prevent complication in lung cancer patients

For many patients with localized lung cancer (non-small-cell lung carcinoma and small cell lung carcinoma), high-dose radiation with concurrent chemotherapy is a potential cure. Yet this treatment can cause severe, acute inflammation of the esophagus (esophagitis) in about one in five patients, requiring hospitalization and placement of a feeding tube.

23 Apr 2021

Scientists identify protein that operates closely with a genetic mutation to spur lung cancer growth

Scientists at VCU Massey Cancer Center have identified a protein that operates in tandem with a specific genetic mutation to spur lung cancer growth and could serve as a therapeutic target to treat the disease.

19 Apr 2021

New microfluidic system effectively isolates cancer spreading cells

The survival rate of cancer patients can drop to ten percent or less during metastasis, the spread of cancerous cells to create secondary tumors.

19 Apr 2021

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Stand Up To Cancer and Mirati Therapeutics Inc. - a late-stage targeted oncology company - today announced that Mirati will contribute a $4 million grant to SU2C to develop new approaches to treat patients with KRAS mutant cancers, as a part of the SU2C Catalyst program.

19 Apr 2021

Three teams selected to receive the first awards from Dartmouth Innovations Accelerator for Cancer

Three teams of Dartmouth researchers have been selected to receive the first awards from the Dartmouth Innovations Accelerator for Cancer.

17 Apr 2021

New recipients for the 2021 NCCN Foundation Young Investigator Awards announced

The National Comprehensive Cancer Network and the NCCN Foundation today announced six new recipients for the 2021 NCCN Foundation Young Investigator Awards Program.

15 Apr 2021

Researchers map the changing trends of cancer burden worldwide and in China

Cancer is one of the leading causes of mortality worldwide, and the global burden of cancer continues to rise steadily and unchecked.

15 Apr 2021

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).

15 Apr 2021

Lung Cancer News and Research

Latest Lung Cancer News and Research

Risk prediction model does not accurately identify lung cancer risks in diverse population

PET imaging can enable accurate diagnosis of recurring brain metastases

Study identifies novel combination therapy to help patients with advanced lung cancer

Study aims to refine delivery of tobacco treatment to people with HIV

Controversial celebrities' illness may negatively affect people's health intentions

Secondhand smoke exposure linked to higher risk of oral cancer

Researchers identify genetic abnormalities that drive invasiveness in head and neck cancer

Study offers insight into how damage to airways of the lung develops into pre-cancer lesions

Preoperative sarcopenia and exercise intolerance predict outcomes following lung cancer surgery

Contralateral esophagus sparing technique can prevent complication in lung cancer patients

Scientists identify protein that operates closely with a genetic mutation to spur lung cancer growth

New microfluidic system effectively isolates cancer spreading cells

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Three teams selected to receive the first awards from Dartmouth Innovations Accelerator for Cancer

New recipients for the 2021 NCCN Foundation Young Investigator Awards announced

Researchers map the changing trends of cancer burden worldwide and in China

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

COVID-19 deadlier than cars for over 40s, study finds

Modified immune cells may prove a game-changer for patients with late-stage cancers

New genetic markers may lead to personalized treatments for lung cancer

The ultimate guide to lung research tools and protocols eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in